Aardvark Therapeutics, Inc.
AARD
$6.41
-$0.16-2.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 33.36% | -22.67% | -7.86% | -13.57% | -54.32% |
| Total Depreciation and Amortization | 0.00% | 10.00% | 0.00% | -9.09% | 120.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.66% | 36.80% | 23.49% | 825.20% | -53.65% |
| Change in Net Operating Assets | -824.90% | 207.43% | 32.63% | -122.78% | 286.04% |
| Cash from Operations | 6.73% | -12.25% | -4.22% | -63.86% | 13.56% |
| Capital Expenditure | -- | -- | 100.00% | 95.60% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.06% | 40.93% | -16.92% | 207.89% | 108.44% |
| Cash from Investing | -16.06% | 40.93% | -16.90% | 210.83% | 108.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,450.00% | -98.54% | 60.23% | 2,750.00% | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 96.67% |
| Cash from Financing | 6,450.00% | -98.54% | 60.23% | 340.85% | -100.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.82% | 98.11% | -41.55% | 2,725.89% | 98.56% |